Clinical Laserthermia Systems AB (publ) (CLS-B) — Net Asset Quality Index
Clinical Laserthermia Systems AB (publ) (CLS-B) has a Net Asset Quality Index of 86.9% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of Skr76.49 Million minus total liabilities of Skr10.00 Million yields net assets of Skr66.48 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check financial resilience of Clinical Laserthermia Systems AB (publ) to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Clinical Laserthermia Systems AB (publ) Net Asset Quality Index Over Time (2008–2025)
This chart shows how Clinical Laserthermia Systems AB (publ)'s Net Asset Quality Index has evolved across 18 annual periods from 2008 to 2025. As of December 2025, the index stands at 86.9%, representing net assets of Skr66.48 Million against total assets of Skr76.49 Million SEK. See how liquid is Clinical Laserthermia Systems AB (publ)'s working capital to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Clinical Laserthermia Systems AB (publ) (2008–2025)
The table below presents the year-by-year Net Asset Quality Index for Clinical Laserthermia Systems AB (publ) from 2008 to 2025, covering 18 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see CLS-B market cap.
| Year | Quality Index | Net Assets (SEK) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 86.9% | Skr66.48 Million | Skr76.49 Million | Skr10.00 Million | ▲ +3.3 pp |
| 2024 | 83.6% | Skr65.69 Million | Skr78.56 Million | Skr12.88 Million | ▲ +8.2 pp |
| 2023 | 75.4% | Skr43.53 Million | Skr57.73 Million | Skr14.20 Million | ▲ +59.5 pp |
| 2022 | 15.9% | Skr7.87 Million | Skr49.51 Million | Skr41.64 Million | ▼ -15.9 pp |
| 2021 | 31.7% | Skr21.18 Million | Skr66.74 Million | Skr45.55 Million | ▲ +0.4 pp |
| 2020 | 31.4% | Skr13.93 Million | Skr44.40 Million | Skr30.47 Million | ▲ +13.3 pp |
| 2019 | 18.1% | Skr7.00 Million | Skr38.67 Million | Skr31.67 Million | ▼ -67.7 pp |
| 2018 | 85.8% | Skr49.81 Million | Skr58.02 Million | Skr8.21 Million | ▲ +12.4 pp |
| 2017 | 73.4% | Skr33.00 Million | Skr44.94 Million | Skr11.94 Million | ▲ +10.9 pp |
| 2016 | 62.5% | Skr17.06 Million | Skr27.30 Million | Skr10.24 Million | ▼ -24.9 pp |
| 2015 | 87.4% | Skr19.46 Million | Skr22.27 Million | Skr2.81 Million | ▲ +2.0 pp |
| 2014 | 85.4% | Skr31.58 Million | Skr36.95 Million | Skr5.38 Million | ▼ -3.9 pp |
| 2013 | 89.4% | Skr26.09 Million | Skr29.20 Million | Skr3.11 Million | ▲ +4.1 pp |
| 2012 | 85.2% | Skr17.09 Million | Skr20.06 Million | Skr2.97 Million | ▲ +1.9 pp |
| 2011 | 83.3% | Skr10.83 Million | Skr13.01 Million | Skr2.17 Million | ▼ -4.8 pp |
| 2010 | 88.1% | Skr10.36 Million | Skr11.76 Million | Skr1.41 Million | ▲ +7.2 pp |
| 2009 | 80.8% | Skr6.63 Million | Skr8.20 Million | Skr1.57 Million | ▲ +14.2 pp |
| 2008 | 66.6% | Skr3.68 Million | Skr5.52 Million | Skr1.85 Million | — |